As 2023 ends, investors are advised to identify 2024 laggards that may rebound in 2025. The Nasdaq Composite is up over 30% for the year, while the S&P 500 and Dow Jones have gained more than 24% and 13%, respectively. However, some individual stocks, like ConocoPhillips, which has dropped over 16%, are expected to recover, with analysts forecasting a 38% upside. Similarly, Nucor’s stock has declined over 33%, but analysts project a potential 31% increase. Regeneron Pharmaceuticals faces a 19% year drop but has over 50% upside potential, spurred by positive treatment developments.
